RxDoctor Payments DataLook up a doctor →

Mercedes Gonzalez, MD

Dermatology · Miami, FLNPI 1750563243

Payments from drug & device makers

$3,584,492in general payments, 2019–2025

Across 1,938 payments — averaging $1849.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$676K
  • Sanofi US Services Inc.$518K
  • Amgen$361K
  • Pfizer$310K
  • AbbVie$254K
  • Incyte Corporation$202K
  • plus $1.3M from 50 others
$301,304in research payments, 2019–2025

Across 43 payments — averaging $7007.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nielsen Biosciences, Inc.$275K
  • Regeneron$20K
  • Pfizer$4K
  • Sanofi$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron237$676,342
Sanofi US Services Inc.85$517,648
Amgen5$361,374
Pfizer149$309,591
AbbVie129$254,081
Incyte Corporation110$201,910
Dermavant Sciences, Inc.282$178,308
Eli Lilly13$167,372
Arcutis Biotherapeutics, Inc.64$165,553
Regeneron Healthcare Solutions, Inc.187$153,069
Sanofi130$148,568
Krystal Biotech Inc44$135,916
Lilly USA, LLC96$92,128
Galderma Laboratories, L.p.91$61,121
Organon49$44,060
Verrica Pharmaceuticals Inc.26$39,649
Chiesi USA, Inc.18$23,878
LNHC, Inc19$16,159
LEO Pharma Inc.32$15,146
Novartis19$6,549
Kowa Pharmaceuticals America, Inc.4$4,375
Abeona Therapeutics, Inc.2$3,025
Amryt Pharma Holdings Ltd2$2,116
EPI Health, LLC1$1,500
Sun Pharmaceutical Industries Inc.39$1,483
Merck1$1,070
Ortho Dermatologics, A Division Of Bausch Health US, LLC13$360
Almirall LLC16$355
Johnson & Johnson5$284
Mayne Pharma Commercial LLC12$169
Sanofi-aventis U.S. LLC3$162
AstraZeneca5$112
Xeris Pharmaceuticals, Inc.5$102
Dermira, Inc.5$96
Nobelpharma America, LLC4$87
VYNE Pharmaceuticals Inc.4$85
Pierre Fabre Pharmaceuticals, Inc.1$83
Strata Skin Sciences, Inc.5$58
Journey Medical Corporation3$54
Ipsen Biopharmaceuticals, Inc2$52
Kerecis Limited1$40
Ascendis Pharma Endocrinology Inc2$38
Mylan Pharmaceuticals Inc.2$37
Insulet Corporation1$36
Tolmar Pharmaceuticals, Inc.2$35
Eton Pharmaceuticals, Inc.2$35
Biofrontera Inc.2$32
UCB, Inc.1$30
Boehringer Ingelheim1$27
Helsinn Therapeutics (U.S.), Inc.1$25
Sandoz1$22
Mallinckrodt Enterprises LLC1$19
Tandem Diabetes Care, Inc.1$18
Botanix SB Inc1$17
Amneal Pharmaceuticals LLC1$15
Novo Nordisk1$14

How this compares

$3,584,492 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$2,894
Medicare patients
11
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →